Altria stock holds its ground as higher smoke-free revenue offsets cigarette volume pressure

Altria stock reflects a shift in its profit mix, with rising contributions from smoke-free products and a sizeable equity stake in Anheuser-Busch InBev shaping investor expectations after the company’s latest full-year 2025 guidance.

Altria Group Inc. (ISIN US02209S1033) reported full-year 2024 net revenues of roughly $25.0 billion and set out guidance for 2025 that keeps profit growth in focus for Altria stock, according to the company’s annual reporting in early 2025. The US tobacco group, whose shares trade on the New York Stock Exchange, is balancing declining cigarette volumes with higher pricing and growing smoke-free revenue.

Revenue near $25 billion and earnings focus

According to Altria’s 2024 annual results, the company generated net revenues of about $25.0 billion in fiscal 2024, compared with roughly $25.5 billion in 2023, highlighting a modest top-line decline as cigarette volumes continued to fall. Management nevertheless emphasized adjusted diluted earnings per share, which they reported at approximately $5.10 for 2024 versus about $4.95 in 2023, demonstrating that margin management and price increases partly offset the revenue headwind.

The company also outlined guidance for 2025 that targets mid-single-digit growth in adjusted diluted earnings per share off the 2024 base, signaling an ambition to continue expanding profitability despite secular volume declines in its traditional combustibles business. In its investor communications, Altria reiterated a dividend payout ratio target of around eighty percent of adjusted diluted earnings per share over time, underlining the importance of cash returns as a key component of the total return case for shareholders.

Smoke-free revenue grows double digits

Altria highlighted that its smoke-free portfolio, which includes oral tobacco and heated tobacco products, posted double-digit revenue growth in 2024, helping to offset declining cigarette shipments. In oral tobacco, net revenues rose to roughly $2.7 billion in 2024 from around $2.4 billion in 2023, an increase of about 12.5%, supported by both pricing and volume gains in modern oral nicotine pouches and moist smokeless tobacco.

In addition, the company reported that smoke-free products represented a rising share of total net revenues and profit contribution in 2024 compared with 2023, underscoring the strategic importance of this category in its long-term transformation plans. Management framed these developments as steps toward a more diversified profit base, seeking to reduce the company’s reliance on traditional combustibles while still leveraging its scale in US nicotine distribution.

Equity stake in Anheuser-Busch InBev supports balance sheet

Altria’s portfolio also includes a significant equity stake in Anheuser-Busch InBev, which management has historically valued at several billion dollars and treated as a financial asset that supports the company’s balance sheet strength. In its 2024 reporting, the company noted that the fair value of this stake contributed to its overall financial flexibility, even though reported earnings can be affected by mark-tomarket movements in the brewer’s share price.

For income-oriented investors, the combination of strong cash generation, a high dividend payout, and additional asset backing from the brewer stake remains an important part of the investment narrative. At the same time, the reliance on a mature US nicotine market and exposure to regulatory shifts around flavor, marketing, and nicotine standards continues to shape the risk profile.

Marlboro brand as core product franchise

Marlboro remains Altria’s flagship cigarette brand in the United States and a key driver of cash flow that funds both shareholder returns and investment in smoke-free initiatives. The company has consistently highlighted Marlboro’s leading market share in the US premium cigarette segment, which helps support pricing power even as industry volumes contract.

In its latest annual discussions, Altria indicated that Marlboro’s share held relatively resilient in 2024 compared with 2023, helped by brand loyalty and distribution reach. The brand’s scale means that small changes in volume or price per pack can have a material impact on group-level revenues and earnings, which is why management focuses heavily on maintaining brand equity while managing down the combustible portfolio over time.

Altria stock and market context

Altria stock is part of the S&P 500 index and is widely held by income-focused portfolios that value its high dividend yield and relatively stable cash flows. On the New York Stock Exchange, the shares have tended to trade in a range that reflects both the high current payout and the structural challenges of a shrinking US cigarette market.

The company’s market capitalization, which has in recent periods been in the tens of billions of dollars, positions it among the larger US consumer staples names, albeit with a more concentrated business profile focused on US nicotine. For investors, the central question remains how successfully Altria can accelerate smoke-free growth and protect its profit pool while continuing to return a substantial portion of earnings to shareholders through dividends and, where appropriate, share repurchases.

Key data on Altria Group Inc.

• Company: Altria Group Inc.
• ISIN: US02209S1033
• Ticker: NYSE: MO
• Trading venue: NYSE
• Market capitalization: tens of billions of USD (recent period)
• Sector / Industry: Consumer Staples / Tobacco
• Index membership: S&P 500